Pfizer and Moderna hike vaccine prices in EU

pharmafile | August 2, 2021 | News story | Sales and Marketing  

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in the EU, as reported in the Financial Times.

Pfizer-BioNTech have hiked their price by 25%, an increase from €15.50 per dose to $19.50.

Moderna will now charge the EU €21.50, an increase of around 13% from the previous €19. This is however lower than the previously agreed $28.50 because the order had grown.

The companies have seen a rise in the amount of purchases as countries have begun to move away from the J&J one-shot vaccine and AstraZeneca.

It is expected they will continue to see an increase if winter booster programmes are initiated.

Brussels has secured up to 4.4 billion doses from six different vaccine makers,  although two jabs have not yet been approved.

Last week, the commission said that the EU is on track to reach its target of fully vaccinating at least 70 percent of the adult population by September.

Pfizer declined to comment to the FT on pricing. Moderna did not respond to the FT’s request for comment on EU pricing.

Lilly Subbotin

Related Content

No items found

Latest content